Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

135 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Pharmacokinetic evaluation and dosing of subcutaneous testosterone pellets.
Pastuszak AW, Mittakanti H, Liu JS, Gomez L, Lipshultz LI, Khera M. Pastuszak AW, et al. Among authors: khera m. J Androl. 2012 Sep-Oct;33(5):927-37. doi: 10.2164/jandrol.111.016295. Epub 2012 Mar 8. J Androl. 2012. PMID: 22403285
Men with BMI ≥ 25 kg/m(2) attained lower TT peaks with slower decay than men with BMI <25 kg/m(2) receiving 10 to 12 pellets, although 300 ng/dL TT levels were reached at approximately 100 days in both groups. ...Men with BMI <25 kg/m(2) should receive …
Men with BMI ≥ 25 kg/m(2) attained lower TT peaks with slower decay than men with BMI <25 kg/m(2) receiving 10 to 12 pellet …
Efficacy of changing testosterone gel preparations (Androgel or Testim) among suboptimally responsive hypogonadal men.
Grober ED, Khera M, Soni SD, Espinoza MG, Lipshultz LI. Grober ED, et al. Among authors: khera m. Int J Impot Res. 2008 Mar-Apr;20(2):213-7. doi: 10.1038/sj.ijir.3901618. Epub 2007 Sep 27. Int J Impot Res. 2008. PMID: 17898800 Clinical Trial.
The role of testosterone replacement therapy following radical prostatectomy.
Khera M, Lipshultz LI. Khera M, et al. Urol Clin North Am. 2007 Nov;34(4):549-53, vi. doi: 10.1016/j.ucl.2007.08.007. Urol Clin North Am. 2007. PMID: 17983894 Review.
Correlation between simultaneous PSA and serum testosterone concentrations among eugonadal, untreated hypogonadal and hypogonadal men receiving testosterone replacement therapy.
Grober ED, Lamb DJ, Khera M, Murthy L, Lipshultz LI. Grober ED, et al. Among authors: khera m. Int J Impot Res. 2008 Nov-Dec;20(6):561-5. doi: 10.1038/ijir.2008.40. Epub 2008 Oct 9. Int J Impot Res. 2008. PMID: 18843272
Testosterone replacement therapy following radical prostatectomy.
Khera M, Grober ED, Najari B, Colen JS, Mohamed O, Lamb DJ, Lipshultz LI. Khera M, et al. J Sex Med. 2009 Apr;6(4):1165-1170. doi: 10.1111/j.1743-6109.2009.01161.x. Epub 2009 Jan 22. J Sex Med. 2009. PMID: 19207277
Androgens and erectile function: a case for early androgen use in postprostatectomy hypogonadal men.
Khera M. Khera M. J Sex Med. 2009 Mar;6 Suppl 3:234-8. doi: 10.1111/j.1743-6109.2008.01159.x. Epub 2009 Jan 21. J Sex Med. 2009. PMID: 19207279 Review.
The quantitative ADAM questionnaire: a new tool in quantifying the severity of hypogonadism.
Mohamed O, Freundlich RE, Dakik HK, Grober ED, Najari B, Lipshultz LI, Khera M. Mohamed O, et al. Among authors: khera m. Int J Impot Res. 2010 Jan-Feb;22(1):20-4. doi: 10.1038/ijir.2009.35. Epub 2009 Aug 6. Int J Impot Res. 2010. PMID: 19657348 Free PMC article.
The female factor: predicting compliance with a post-prostatectomy erectile preservation program.
Moskovic DJ, Mohamed O, Sathyamoorthy K, Miles BJ, Link RE, Lipshultz LI, Khera M. Moskovic DJ, et al. Among authors: khera m. J Sex Med. 2010 Nov;7(11):3659-65. doi: 10.1111/j.1743-6109.2010.02014.x. Epub 2010 Aug 31. J Sex Med. 2010. PMID: 20819141
Androgen replacement therapy after prostate cancer treatment.
Khera M. Khera M. Curr Urol Rep. 2010 Nov;11(6):393-9. doi: 10.1007/s11934-010-0143-3. Curr Urol Rep. 2010. PMID: 20838944
Testosterone therapy in men with untreated prostate cancer.
Morgentaler A, Lipshultz LI, Bennett R, Sweeney M, Avila D Jr, Khera M. Morgentaler A, et al. Among authors: khera m. J Urol. 2011 Apr;185(4):1256-60. doi: 10.1016/j.juro.2010.11.084. Epub 2011 Feb 22. J Urol. 2011. PMID: 21334649
135 results
Jump to page
Feedback